HMD 4.17% 2.3¢ heramed limited

Ann: Sheba Expands Pilot to include High-Risk Pregnancies, page-33

  1. 13,446 Posts.
    lightbulb Created with Sketch. 2634
    This has to be the best video I've seen yet involving HeraCARE - a webinar with Dr Avi Tsur (Director of Sheba's Women's Health Innovation Centre - and lead of the HeraCARE trial) pitching to the Canada Friends of Sheba last week

    This is exciting for a number of reasons:

    1. Dr Avi Tsur is clearly very POSITIVE about the trial (a 'big revolution' to use his words - 'it will change everything we do')
    2. One of Sheba Hospital's brightest registrars - Dr Michal Axelrod ( https://www.researchgate.net/profile/Michal-Axelrod-3) was pregnant during the ante-natal Covid clinic trial and personally used the HeraCARE platform and found it very user-friendly and was able to provide input into improving protocols and workflows
    3. Even the ultra conservative Orthodox patients - without smartphones - had no problems negotiating the tools (e.g. HeraBEAT)and platform
    4. Based on the Covid clinic trial success - the trial has been extended to both 'post-term' and 'high risk' pregnancies, in remote situations
    5. Dr Tsur makes it very clear that - pending success of the trial - the plan is to go global with the remote monitoring platform and tools (comprising HeraCARE and PulseNmore)

    The trial proper - following set up - is die to commence in 3 weeks according to Dr Tsur.

    The whole video is interesting, but the most relevant section runs from 21.20mins to 33.40 mins.


 
watchlist Created with Sketch. Add HMD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.